Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors

European Journal of Medicinal Chemistry

Volumn 43, Issue 2, 2008, Pages 293-299

  Nair, Pramod C ^a   Sobhia, M Elizabeth ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Descriptors; GFA; Influenza; Neuraminidase; QSAR; Thiourea

Indexed keywords

SIALIDASE; SIALIDASE INHIBITOR; THIOUREA DERIVATIVE;

ARTICLE; CONTROLLED STUDY; ELECTRONICS; ENZYME INHIBITION; GENE FUNCTION; GENETIC ALGORITHM; INFLUENZA VIRUS; MOLECULAR MODEL; NONHUMAN; PREDICTION; PROTEIN LOCALIZATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; THERMODYNAMICS; VALIDATION PROCESS;

ENZYME INHIBITORS; NEURAMINIDASE; ORTHOMYXOVIRIDAE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REGRESSION ANALYSIS; THIOUREA;

EID: 38949167100     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.03.020     Document Type: Article

References (28)

1. Patterson K.D., and Pyle G.F. Bull. Hist. Med. 65 (1991) 4-21
2. Taubenberger J.K., Reid A.H., Krafft A.E., Bijwaard K.E., and Fanning T.G. Science 275 (1997) 1793-1796
3. Ghedin E., Sengamalay N.A., Shumway M., Zaborsky J., Feldblyum T., Subbu V., Spiro D.J., Sitz J., Koo H., Bolotov P., Dernovoy D., Tatusova T., Bao Y., St George K., Taylor J., Lipman D.J., Fraser C.M., Taubenberger J.K., and Salzberg S.L. Nature 437 (2005) 1162-1166
4. Boni M.F., Gog J.R., Andreasen V., and Feldman M.W. Proc. Biol. Sci. 273 (2006) 1307-1316
5. Cox N.J., and Subbarao K. Annu. Rev. Med. 51 (2000) 407-421
6. Hay A.J., Wolstenholme A.J., Skehel J.J., and Smith M.H. EMBO J. 4 (1985) 3021-3024
7. Hastings J.C., Selnick H., Wolanski B., and Tomassini J.E. Antimicrob. Agents Chemother. 40 (1996) 1304-1307
8. Mammen M., Dahmann G., and Whitesides G.M. J. Med. Chem. 38 (1995) 4179-4190
9. Colman P.M. Expert Rev. Anti Infect. Ther. 3 (2005) 191-199
10. Wilson J., and von Itzstein M. Curr. Drug Targets 4 (2003) 389-408
11. Moscona A. N. Engl. J. Med. 353 (2005) 1363-1373
12. Hayden F.G., Belshe R.B., Clover R.D., Hay A.J., Oakes M.G., and Soo W. N. Engl. J. Med. 321 (1989) 1696-1702
13. Colman P.M., Varghese J.N., and Laver W.G. Nature 303 (1983) 41-44
14. Varghese J.N., McKimm-Breschkin J.L., Caldwell J.B., Kortt A.A., and Colman P.M. Proteins 14 (1992) 327-332
15. von Itzstein M., Wu W.Y., Kok G.B., Pegg M.S., Dyason J.C., Jin B., Van P.T., Smythe M.L., White H.F., and Oliver S.W. Nature 363 (1993) 418-423
16. Verma R.P., and Hansch C. Bioorg. Med.Chem. 14 (2006) 982-996
17. Sun C., Zhang X., Huanga H., and Zhoua P. Bioorg. Med. Chem. 14 (2006) 8574-8581
18. SYBYL Molecular Modeling System, version 7.1, Tripos Inc., St. Louis, MO, 63144-2913.
19. Gasteiger J., and Marsili M. Tetrahedron 36 (1980) 3219-3228
20. Powell M.J.D. Math. Program. 12 (1977) 241-254
21. 2 version 4.9, Accelrys Inc., 6985 Scranton Road, San Diego, CA, USA.
22. de Gregorio C., Kier L.B., and Hall L.H. J. Comput. Aided Mol. Des. 12 (1998) 557-561
23. Kier L.B., and Hall L.H. Pharm. Res. 7 (1990) 801-807
24. Estrada E., and Uriarte E. Curr. Med. Chem. 8 (2001) 1573-1588
25. Rogers D., and Hopfinger A.J. J. Chem. Inf. Comput. Sci. 34 (1994) 854-866
26. Shi L.M., Yi F., Myers T.G., O'Connor P.M., Paull K.D., Friend S.H., and Weinstein J.N. J. Chem. Inf. Comput. Sci. 38 (1998) 189-199
27. Ghose A.K., and Crippen G.M. J. Chem. Inf. Comput. Sci. 7 (1987) 21-35
28. Ghose A.K., Viswanadhan V.N., Revankar G.R., and Robins R.K. J. Chem. Inf. Comput. Sci. 29 (1989) 163-172